MedTrace Logo

A Prospective Study of Airless Tubing in an Inpatient Acute Hemodialysis Unit in Hospitalized Patients

NCT02086682 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 338

Last updated 2019-07-15

Study results available
· View outcomes & findings →

Summary

The introduction of unfractionated heparin (UFH), which prevents clotting of the extracorporal circuit, was one of the key advances that led to the rapid development and expansion of hemodialysis services. However, anticoagulation during hemodialysis of the patient at high risk for bleeding remains a frequently encountered problem in both inpatient and outpatient dialysis practice.

Streamline bloodlines are designed to eliminate blood-air contact. This is thought to help reduce heparin use and decrease clotting rates. The goal of this study was to prospectively examine impact of the Streamline airless blood tubing set, in an inpatient setting, on dialysis circuit clotting rates, anticoagulation use, and dialysis efficiency.

Conditions

  • End Stage Renal Failure on Dialysis
  • Complication of Dialysis
  • Blood Coagulation Disorders

Sponsors & Collaborators

  • NxStage Medical

    collaborator OTHER

  • Marie Hogan

    lead OTHER

Principal Investigators

  • Marie C. Hogan, M.D., Ph.D. · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02086682 on ClinicalTrials.gov